You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

59 Results
Recommandations fondées sur les données probantes de ContrôleCancerColorectal, le programme ontarien de dépistage du cancer colorectal. Aussi...
Guidelines and Advice
Status: Current
ID: GL 2-30a
Version: N/A
Mar 2020
Guidelines and Advice
Status: Current
ID: GL 2-33
Version: 2
Jun 2025
Guidelines and Advice
Jan 2020
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-10
Version: 1
May 2021
Guidelines and Advice
Dec 2015
Guidelines and Advice
Guidelines and Advice
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma
Jun 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma
Jun 2025

Pages